Ophirex, Inc

Ophirex, Inc., a Public Benefit Corp. focused on treatments for acute, life-threatening illnesses, is modernizing the treatment of snakebite victims by developing an affordable, accessible, oral treatment for immediate use anywhere a snakes bite occurs. Approximately 80% of the worlds population lives in close proximity to at least one venomous snake species and more than 500,000 people are killed or maimed by snakes each year worldwide.[1][2] Field treatments could help save hundreds of thousands of lives and limbs annually and provide enormous savings in healthcare costs.[2][3] Ophirex is developing a time of bite oral snakebite treatment that blocks the most commonly lethal component of snake venompresent in 95% of the worlds venomous snakes.[4] This antidotenow in human clinical trialscan be administered immediately in the field or in the hospital to effectively stop the venoms devastating assault.[5][6][7] 1. Vulnerability to snakebite envenoming: a global mapping of hotspot...